Nanobiotix SA (GB:0QAV)
LSE:0QAV
Holding GB:0QAV?
Track your performance easily

Nanobiotix (0QAV) Income Statement

4 Followers

Nanobiotix Income Statement

Last quarter (Q ), Nanobiotix's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Nanobiotix's net income was $―. See Nanobiotix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
-$ 4.78M$ 2.65M$ 2.51M$ 68.00K$ 116.00K
Cost of Revenue
------
Gross Profit
-$ 4.78M$ 10.00K$ 50.00K--
Operating Expense
-$ 64.36M$ 49.81M$ 36.30M$ 46.85M$ 30.18M
Operating Income
-$ -64.36M$ -49.80M$ -36.24M$ -46.78M$ -30.07M
Net Non Operating Interest Income Expense
-$ 3.53M$ 6.36M$ 201.00K$ -4.55M$ -726.00K
Other Income Expense
-$ -3.79M$ 2.78M$ -2.46M$ 423.00K-
Pretax Income
-$ -57.03M$ -47.00M$ -33.58M$ -50.91M$ -30.34M
Tax Provision
-$ 10.00K$ 5.00K$ 9.00K$ 3.00K$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-$ -57.04M$ -47.00M$ -33.59M$ -50.91M$ -30.34M
Basic EPS
----$ -2.35$ -1.55
Diluted EPS
----$ -2.35$ -1.55
Basic Average Shares
----$ 21.63M$ 19.63M
Diluted Average Shares
----$ 21.63M$ 19.63M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----$ 9.44M$ 5.92M
Total Expenses
-$ 64.36M$ 49.81M$ 36.30M$ 46.85M$ 30.18M
Net Income From Continuing And Discontinued Operation
-$ -57.04M$ -47.00M$ -33.59M$ -50.91M$ -30.34M
Normalized Income
----$ -51.34M$ -30.34M
Interest Expense
----$ 4.79M$ 847.00K
EBIT
-$ -51.43M$ -46.62M$ -33.58M$ -46.12M$ -29.50M
EBITDA
-$ -49.93M$ -45.06M$ -31.83M$ -44.35M$ -28.88M
Currency in USD

Nanobiotix Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis